Research in Urology

AUI VUI Presentations

AUA VUI 2023 Presentations

Presentor	Presentation
Matt Davis	23-1415 Frequentist and Bayesian Analysis of Potential Adverse Events of the COVID-19 Immunization
Matt Davis	23-6375 Industry Payments to Urologists Since the Sunshine Act
Matt Davis	23-6404 Industry Payments to Urologists Since the COVID-19 Pandemic
Matt Davis	23-6202 Evaluating The Impact of COVID-19 Pandemic on Prostate-Specific Antigen Testing in a North American Population: a health system-wide analysis
Matt Davis	23-6366 Impact of Age and Race on Prostate-Specific Antigen Testing in Response to the COVID-19 Pandemic
Matt Davis	23-6428 Is there a Role for Radical Cystectomy in treating patients with Metastatic Plasmacytoid Bladder Cancer Patients? A Nationwide cohort analysis.
Matt Davis	23-6474 Baseline PSA levels in midlife & future development of lethal prostate cancer: A diverse North American cohort analysis
Matt Davis	23-6439 Impact of PSA testing pattern on cancer mortality among Black and White men diagnosed with prostate cancer: A large, urban health system cohort analysis
Matt Davis	23-6454 Gender Gap in Industry Payments to Urologists
Matt Davis	23-8497 Racial disparities in future development of lethal prostate cancer based on PSA levels in midlife
Sami Majdalany	Robotic Radical Cystectomy, Paravaginal Repair & Intracorporeal Neobladder
Sami Majdalany	Watt’s In a Name? - The People that Focused Laser Lithotripsy
Sami Majdalany	Rolling with the Stones - Evolution of Stone Extraction
Sami Majdalany	Stents and Shockwave Lithotripsy – the Who and the Why: Results from a Statewide Surgical Collaborative (MUSIC)
Russell E.N. Becker	Daily Ecological Momentary Assessments of Pain and Ability to Work after Ureteroscopy and Stenting
Emily Chan Brodowsky	Multi-quadrant Robotic Surgery: Adrenalectomy and Paraganglioma Excision
Emily Chan Brodowsky	Robotic Single Port Pyelolithotomy for a Pelvic Kidney
Taylor Malchow	23-7062 Application and survival outcomes of landmark prostate specific antigen screening trial protocols in an urban healthcare system
Ivan Rakic	23-8653 Evaluating the role of lymphvascular invasion as an indicator for adverse outcomes for patients with upper tract urothelial carcinoma and its histological subtypes
Ivan Rakic	23-8668 The impact of histological subtypes on stage at presentation and overall survival of patients with upper tract urothelial carcinoma: A nationwide cohort analysis
Ivan Rakic	23-8607 Is there a racial disparity in the outcomes of patients with non-metastatic upper urothelial carcinoma who are treated surgically? A north american nationwide analysis
Sohrab Arora	23-8612 Do saturation prostate biopsies provide additional clinically significant information in patients with MRI identified lesions sampled at the same time?
Sohrab Arora	23-8647 Inpatient outcomes of radical nephroureterectomy (NU) for upper tract urothelial cancer (UTUC), with trends in utilization and impact of robotic surgery – National Inpatient Sample (NIS) analysis.
Sohrab Arora	Outcomes of Precision Prostatectomy procedure for localized prostate cancer, and step-by-step technique of single port transvesical Precision Prostatectomy
Sohrab Arora	Impact of a novel anterior suspension stitch on return of urinary continence after Robot-assisted Radical Prostatectomy with description of surgical technique
Sohrab Arora	23-8594 Inpatient outcomes of simultaneous radical cystectomy and nephroureterectomy in the United States: Retrospective analysis of the National Inpatient Sample
Sami Wilder	23-8213 - Using the Multiport da Vinci Xi System as a Training Platform for Single Port Robotic Prostatectomy
Sami Wilder	23-8060 - Three-Year Follow-Up for Surveillance of T1 Renal Masses: A MUSIC-KIDNEY Analysis
Sami Wilder	23-7800 - Practice and surgeon-level variation in the surgical management of T1a renal masses: Results from a statewide collaborative
Sami Wilder	23-6559 - Practice-Level Variation in Opioid-Free Discharge Following Surgery for T1 Renal Masses: A MUSIC-KIDNEY Analysis
Ethan Ferguson	Extraperitoneal Single-Port Robotic Radical Prostatectomy in over 700 patients: Updated Multi-Institutional Cohort Study from the SPARC Collaboration
Ethan Ferguson	Single-Port Robotic Radical Prostatectomy in over 1,100 Consecutive Patients from the Multi-Institutional SPARC Collaboration
Ethan Ferguson	Same-Day Discharge in Single-Port Robotic Radical Prostatectomy: Evaluation of Predictors and Postoperative Outcomes from the Multi-Institutional SPARC collaboration
Michael Wang	Dueling Active Surveillance: Does Utilization of Active Surveillance for Low Risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?
Mahmoud Hijazi	Use of aVirtualTumorBoard to Discuss Renal Masses: Experience from a Quality Improvement Collaborative- no concerns with abstract.
Allison May	Surveillance of cT1 renal masses is common in patients with CKD
Mohit Butaney	23-9548 An Intermediate-term oncological assessment comparing the retzius-sparing RARP to the standard approach in a randomized control cohort
Mohit Butaney	23-8318 - Efficiency and User Satisfaction of Single-Use vs Reusable Cystoscopes in a High-Volume Urology Clinic
Ajay Gopalakrishna	Approach to Robotic-Assisted Radical Nephrectomy in Patients with Severe Morbid Obesity
Courtney Yong
Nick Corsi	Radical Therapy for Low-Risk Upper Tract Urothelial Carcinoma (ROBUUST Collaborative Group)
Nick Corsi	TESTING THE EXTERNAL VALIDITY OF THE POUT III TRIAL (ADJUVANT PLATNIUM-BASED CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CARCINOMA) IN A NORTH AMERICAN COHORT
Gabriele Tuderti	ROLE OF PERIOPERATIVE CHEMOTHERAPY IN UPPER TRACT UROTHELIAL CARCINOMA PATIENTS UNDERGOING NEPHROURETERECTOMY: ANALYSIS FROM THE ROBUUST 2.0 REGISTRY
Sohail Dhanji	HYPERTENSION IS ASSOCIATED WITH WORSENED ONCOLOGICAL SURVIVAL OUTCOMES IN PATIENTS UNDERGOING NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY
Savio Pandolfo	PREDICTIVE FACTORS OF COMPLICATIONS AND READMISSIONS IN PATIENTS UNDERGOING MINIMALLY INVASIVE RADICAL NEPHROURETERECTOMY

AUA VUI 2022 Presentations

Presentor	Presentation
Taylor Malchow	MP53-19 PROSTATE SPECIFIC ANTIGEN SCREENING UTILIZATION IN MEN WITH A FAMILY HISTORY OF PROSTATE CANCER AND EXTENDED LIFE EXPECTANCY
Mohit Butaney	PD25-07 RACIAL DISPARITIES IN SURGICAL TREATMENT OF RENAL MASSES: INITIAL ANALYSIS OF A STATEWIDE REGISTRY
Nicholas Corsi	PD17-10 PROSTATE SPECIFIC ANTIGEN SCREENING ON A NATIONWIDE LEVEL: FEATURING THE CONTRIBUTION OF RACE AND LIFE EXPECTANCY IN DECISION MAKING
Nicholas Corsi	MP40-06 ROLE OF NEOADJUVANT CHEMOTHERAPY IN PATHOLOGICAL DOWNSTAGING DURING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP)
Margaret Meagher	PD15-06 ELEVATED HEMOGLOBIN:CREATININE RATIO IS A NOVEL PREOPERATIVE MARKER FOR WORSENED SURVIVAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS FROM THE ROBUUST REGISTRY
Kevin Hakimi	PD58-07 IMPACT OF NODE COUNT ON SURVIVAL OUTCOMES OF LYMPH NODE DISSECTION IN NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY
Kevin Hakimi	PD58-11 IMPACT OF PRE-OPERATIVE KIDNEY FUNCTION ON SURVIVAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY
Alison Levy	V07-03 SOLVING CLINICAL CHALLENGES IN PROSTATECTOMY USING SINGLE-PORT ROBOT SYSTEM: A CASE SERIES
Mohit Butaney	MP16-03 STONE MANAGEMENT IN THE SOLITARY KIDNEY, ARE WE DOING THINGS DIFFERENTLY? RESULTS FROM A STATEWIDE CLINICAL REGISTRY
Mohit Butaney	MP47-06 ASSESSING RENAL MASS MANAGEMENT OF PATIENTS WITH INCREASED COMORBIDITIES: RESULTS FROM A STATEWIDE REGISTRY
Mohit Butaney	PD33-02 EVALUATION OF AN UNCOMPLICATED RECOVERY AFTER NEPHRECTOMY: MUSIC-KIDNEY NOTES (NOTABLE OUTCOMES AND TRACKABLE EVENTS AFTER SURGERY)
Mohit Butaney	MP16-04 PRACTICE-LEVEL VARIATION IN RATES POSITIVE SURGICAL MARGINS AT PARTIAL NEPHRECTOMY: A MUSIC-KIDNEY ANALYSIS
Mohit Butaney	MP39-12 REDUCING POST-OPERATIVE EMERGENCY DEPARTMENT VISITS AND READMISSIONS AFTER NEPHRECTOMY: AN INITIAL EVALUATION OF THE MUSIC-KIDNEY REGISTRY
Isaac Palma-Zamora	MP13-12 PRACTICE PATTERNS AND PREDICTORS OF URINARY STONE MATERIAL SUBMISSION FOR ANALYSIS FOLLOWING URETEROSCOPY: RESULTS FROM A STATEWIDE SURGICAL COLLABORATIVE
Marcus Jamil	V03-02 EX-VIVO URETEROSCOPY FOR THE TREATMENT OF NEPHROLITHIASIS IN A DECEASED DONOR KIDNEY PRIOR TO TRANSPLANTATION

AUA VUI 2021 Presentations

Presentor	Presentation
Akshay Sood	PD19-11 THE PRECISION PROSTATECTOMY: A NOVEL SURGICAL FORM OF FOCAL THERAPY
Deepansh Dalela	PD50-03 PSA SCREENING IN US MEN WITH FAMILY HISTORY OF PROSTATE CANCER: A CONTEMPORARY NATIONWIDE SURVEY
Mahdi Bazzi	PD60-11 HYPOGONADISM PREDICTS HOSPITAL ADMISSION IN MEN WITH COVID-19 INFECTION
Deepansh Dalela	PD50-04 RACIAL DISPARITIES IN PSA SCREENING IN US MEN WITH FAMILY HISTORY OF PROSTATE CANCER: A CONTEMPORARY NATIONWIDE SURVEY
Akshay Sood	PD13-03 MORTALITY FROM SECONDARY CANCERS IN MEN TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER: AN INSIGHT INTO PROSTATE CANCER SURVIVORSHIP AT 15-YEARS OF FOLLOW-UP
Marcus Jamil	MP45-07 RENAL MASS SIZE AND PRESENCE OF SYNCHRONOUS LUNG METASTASIS AT TIME OF DIAGNOSIS: IMPLICATIONS FOR CHEST IMAGING
Nicholas Corsi	MP16-17 ESTIMATING RECURRENCE-FREE SURVIVAL OF NON-MUSCLE INVASIVE BLADDER CANCER AFTER INTRAVESICAL THERAPY: A CLINICAL-BASED RECURSIVE PARTITION ANALYSIS
Emily Chan	PD08-08 TIME TO SECOND BIOCHEMICAL RECURRENCE AS A PROGNOSTIC INDICATOR IN POST-PROSTATECTOMY PATIENTS WHO UNDERGO SALVAGE RADIATION THERAPY: AN RTOG 9601 BASED POST-HOC ANALYSIS
Deepansh Dalela	PD65-02 IMPACT OF PROSTATE-SPECIFIC ANTIGEN (PSA) SCREENING INTENSITY ON PROSTATE CANCER DIAGNOSIS IN A RACIALLY DIVERSE HEALTHCARE SYSTEM OVER A 25-YEAR PERIOD
Nikola Rakic	MP45-19 EVALUATION OF THE UTILITY OF LYMPH-VASCULAR INVASION AS AN INDEPENDENT PROGNOSTIC PREDICTOR OF OVERALL SURVIVAL FOR PATIENTS WITH RENAL CELL CARCINOMA THAT UNDERGO NEPHRECTOMY
Marcus Jamil	MP30-01 AGE AND RACE ADJUSTED PROSTATE SPECIFIC ANTIGEN VALUES IN MEN WHO PRESENTED TO A SINGLE URBAN TERTIARY HEALTH CARE CENTER: A 25 YEAR EXPERIENCE
Deepansh Dalela	PD65-05 RACIAL DISPARITY IN PROSTATE CANCER DIAGNOSIS FOR MEN UNDERGOING VARYING INTENSITY OF PROSTATE-SPECIFIC ANTIGEN (PSA) SCREENING IN A LARGE, RACIALLY DIVERSE HEALTHCARE SYSTEM
Sohrab Arora	MP49-09 IMPACT OF PREEXISTING OPIOID-DEPENDENCE ON MORBIDITY, LENGTH OF STAY, AND INPATIENT COST OF UROLOGIC ONCOLOGIC SURGERY
Chandler Bronkema	PD57-02 NATIONAL CANCER DATABASE ANALYSIS ASSESSING THE IMPACT OF TREATMENT MODALITIES ON SURVIVAL OUTCOMES IN LOCALIZED NEUROENDOCRINE PROSTATE ADENOCARCINOMA
Nikola Rakic	PD19-12 EXAMINING THE PREDICTIVE ROLE OF LYMPH-VASCULAR INVASION IN PATIENTS WITH VERY HIGH-RISK PROSTATE CANCER
Akshay Sood	PD34-04 ANTI-ANDROGEN THERAPY OVERCOMES THE TIME-DELAY IN INITIATION OF SALVAGE RADIATION THERAPY AND RESCUES THE ONCOLOGICAL OUTCOMES IN MEN WITH RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
Akshay Sood	MP58-09 RISK OF 30-DAY MORTALITY AND CARDIOPULMONARY COMPLICATIONS IN PATIENTS UNDERGOING EMERGENCY SURGERY WITH PERIOPERATIVE SARS-COV-2 INFECTION
Kevin Hakimi	PD43-08 OUTCOMES OF LYMPH NODE DISSECTION IN NEPHROURETERECTOMY IN THE TREATMENT OF UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY
Alexander P. Kenigsberg	MP48-11 PERIOPERATIVE INTRAVESICAL CHEMOTHERAPY IN MINIMALLY INVASIVE RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: LOW BUT INCREASING UTILIZATION WORLDWIDE
Richard C Wu	MP30-08 BARRIERS TO ADOPTION AND IMPLEMENTATION OF TRANSPERINEAL PROSTATE BIOPSY UNDER LOCAL ANESTHESIA
Ajith Dupati	MP64-17 PREDICTING LONG-TERM SEXUAL FUNCTION IN POST-RADICAL PROSTATECTOMY PATIENTS BASED ON MRI AND CLINICAL FACTORS: A MULTI-CENTER STUDY
Akshay Sood	Mortality from Secondary Cancers in Men Treated with Radical Prostatectomy for Prostate Cancer: An Insight into Prostate Cancer Survivorship at 15-Years of Follow-up
Nicholas Corsi	Recurrence free survival in NMIBC after intra-vesicle therapy: a clinical based recursvie partition analysis
Marcus Jamil	Urinary Catheter Alleviation Navigator Protocol (Ucanp): Pilot to Reduce Urinary Catheter Reinsertion in Patients in Urinary Retention
Craig G Rogers	Barriers to adoption and implementation of Transperineal Prostate Biopsy under local anesthesia
Alice Semerjian	Which patient and tumor factors make radical nephrectomy appropriate treatment for suspicious cT1 renal masses?
Zach Prebay	Perspectives on the Role of Biopsy for Management of T1 Renal Masses: Results from Two Quality Improvement Collaboratives.
Mohit Butaney	Initial Management of Indeterminate Renal Masses in a Statewide Collaborative:a MUSIC-KIDNEY analysis
Sara	Documentation of Nephrometry Scores for cT1a Renal Masses Correlates with Avoidance of Radical Nephrectomy Across the MUSIC-KIDNEY Statewide QI Collaborative
Natalija Kovacevic	Disparity in Female Pelvic Examinations in the Evaluation of Lower Urinary Tract Symptoms
Ajith Dupati	Predicting Long-term Sexual Function in Post-Radical Prostatectomy Patients Based on MRI and Clinical Factors: A Multi-center Study

AUA VUI 2020 Presentations

Presentor	Presentation
Eugune Cone	PD16-09 ABIRATERONE IS ASSOCIATED WITH HIGHER ODDS OF CARDIAC COMPLICATIONS COMPARED TO ENZALUTAMIDE
Deepansh Dalela	PD38-01 VALIDITY OF PSA SCREENING TRIALS IN A 'REAL WORLD' SETTING: A NATIONWIDE SURVEY ANALYSIS
Marcus Jamil	MP50-10 LONG-TERM RISK OF RECURRENCE IN SURGICALLY TREATED RENAL CELL CARCINOMA: A POST-HOC ANALYSIS OF THE EASTERN COOPERATIVE ONCOLOGY GROUP - AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK (ECOG-ACRIN) E2805 TRIAL COHORT
Natalija Kovacevic	MP79-08 IDENTIFYING PATIENTS THAT MAY BENEFIT FROM ADDITION OF BICALUTAMIDE TO SALVAGE RADIATION THERAPY IN THE SETTING OF BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY
Chandler Bronkema	MP67-18 IMPACT OF TREATMENT MODALITY ON OVERALL SURVIVAL IN LOCALIZED DUCTAL PROSTATE ADENOCARCINOMA: A NATIONAL CANCER DATABASE ANALYSIS
Marcus Jamil	MP62-03 IMPACT OF LYMPHOVASCULAR INVASION ON OVERALL SURVIVAL IN PATIENTS WITH PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY STRATIFIED BY PATHOLOGICAL TUMOR STAGE
Deepansh Dalela	PD48-09 PROSTATE SPECIFIC ANTIGEN (PSA) SCREENING UTILIZATION HAS SIGNIFICANTLY DROPPED OVER THE LAST TWO DECADES, EVEN IN MEN WITH EXTENDED LIFE-EXPECTANCY: A NATIONWIDE ANALYSIS
Chandler Bronkema	PD13-05 NATIONAL CANCER DATABASE COMPREHENSIVE SURVIVAL ANALYSIS OF NONMETASTATIC RARE HISTOLOGICAL VARIANT PROSTATE ADENOCARCINOMA
Sohrab Arora	MP21-01 IMPACT OF PREEXISTING OPIOID DEPENDENCE ON MORBIDITY, LENGTH OF STAY, AND INPATIENT COST OF SURGERY FOR KIDNEY CANCER
Akshay Sood	MP79-09 ANTI-ANDROGEN THERAPY OVERCOMES THE TIME-DELAY IN INITIATION OF SALVAGE RADIATION THERAPY AND RESCUES ONCOLOGICAL OUTCOMES IN MEN WITH RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
Isaac Palma-Zamora	MP81-07 COMPARISON OF SYSTEMATIC 12-CORE PROSTATE BIOPSY AND MAGNETIC RESONANCE IMAGING FUSION PROSTATE BIOPSY TO THE FINAL SURGICAL PATHOLOGY
Akshay Sood	PD15-12 USE OF ULTRA-LOW DOSE COMPUTED TOMOGRAPHY VERSUS ABDOMINAL PLAIN FILM FOR ASSESSMENT OF STONE-FREE RATES AFTER SHOCK-WAVE LITHOTRIPSY (SWL): IMPLICATIONS ON SUBSEQUENT EMERGENCY ROOM VISITS, SURGICAL PROCEDURES AND COST-EFFECTIVENESS
Ali A Dabaja	MP12-15 ADDITION OF PREOPERATIVE PROSTATE MRI VARIABLES IMPROVES PREDICTION OF EARLY SOCIAL CONTINENCE AFTER RADICAL PROSTATECTOMY: A MULTI-INSTITUTIONAL ANALYSIS
Alexander P Cole	MP79-10 A SMARTPHONE-BASED MOBILE HEALTH APP TO ADDRESS THE ADVERSE EFFECTS OF ANDROGEN DEPRIVATION THERAPY IN MEN WITH PROSTATE CANCER

AUA VUI 2019 Presentations

Presentor	Presentation
Firas Abdollah	MP72-06 EVALUATING THE IMPACT OF LEAD-TIME BIAS ON THE OBSERVED EFFICACY OF EARLY SALVAGE RADIATION THERAPY IN PROSTATE CANCER: A POST-HOC ANALYSIS OF THE RTOG 9601 TRIAL
Sohrab Arora	PD25-12 INPATIENT MORBIDITY AND COST OF CYTOREDUCTIVE RADICAL PROSTATECTOMY IN THE UNITED STATES
Akshay Sood	PD15-06 RATES AND PATTERNS OF METASTASES IN PATIENTS WITH NODE-NEGATIVE PROSTATE CANCER AT RADICAL PROSTATECTOMY THAT EXPERIENCE PSA FAILURE: POST-HOC ANALYSIS OF RTOG 9601 TRIAL DATA
Audrey Fotouhi	MP60-01 THE CHANGING FACE OF SURGICALLY TREATED LOW-RISK PROSTATE CANCER: A NATIONAL CANCER DATABASE ANALYSIS
Nikola Rakic	MP72-11 PERSISTENT UNDER-UTILIZATION OF ADJUVANT RADIOTHERAPY IN PATIENTS WITH ADVERSE PATHOLOGICAL FEATURES AT RADICAL PROSTATECTOMY (RP): A NATIONAL CANCER DATABASE (NCDB) ANALYSIS
Sohrab Arora	MP77-17 ADMISSION RATES, HEALTHCARE UTILIZATION, AND ECONOMIC BURDEN OF RADIATION CYSTITIS (RC) IN THE UNITED STATES
Hernan Lescay	MP54-11 PELVIC LYMPH NODE DISSECTION DURING ROBOTIC PROSTATECTOMY IN THE MUSIC COLLABORATIVE
Sohrab Arora	MP41-17 RARE HISTOLOGICAL VARIANTS OF PROSTATE ADENOCARCINOMA (PCA): A NATIONAL CANCER DATABASE (NCDB) ANALYSIS
Sohrab Arora	PD03-07 TESTING THE EXTERNAL VALIDITY OF CARMENA TRIAL COMPARING SUNITINIB ALONE OR AFTER NEPHRECTOMY IN METASTATIC RENAL-CELL CARCINOMA
Lee Baumgarten	MP72-03 IMPACT OF TIMING ON RADIATION THERAPY ADVERSE EVENTS FOLLOWING RADICAL PROSTATECTOMY: A SECONDARY ANALYSIS OF THE RTOG 9601 COHORT
Wei Shen Tan	MP66-05 VARIATION IN POSITIVE SURGICAL MARGIN STATUS FOLLOWING RADICAL PROSTATECTOMY FOR PT2 PROSTATE CANCER
Sohrab Arora	PD41-02 FEASIBILITY OF OMITTING OUTER (CORTICAL) RENORRHAPHY DURING ROBOTIC PARTIAL NEPHRECTOMY - A MULTI-INSTITUTIONAL ANALYSIS
Zade Roumayah	MP13-17 PREVALENCE OF CRITERIA FOR GENETIC TESTING ACCORDING TO THE NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES IN A CONTEMPORARY COHORT OF POST PROSTATECTOMY MEN WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER: THE HENRY FORD HEALTH SYSTEM EXPERIENCE
Moustafa Deebaja	MP09-20 THE DISTRIBUTION OF COMEDONECROSIS IN INTRADUCTAL VERSUS INVASIVE PROSTATE CANCER: ANALYSIS FROM A LARGE SINGLE CENTER PROSTATECTOMY SERIES
Shaheen Alanee	MP09-09 THE ASSOCIATION BETWEEN PATHOLOGIC FEATURES OF LYMPH NODE METASTASIS IDENTIFIED AFTER PROSTATECTOMY AND THE RISK OF BIOCHEMICAL RECURRENCE: A STUDY OF 280 CASES
Grace Yaguchi	MP13-03 NEED FOR SYSTEMIC 12-CORE BIOPSY CONCURRENT WITH MRI TARGETED BIOPSY OF PI-RADS 4 AND PI-RADS 5 LESIONS
Ahmed A Hussein	MP26-11 TEN-YEAR ONCOLOGIC OUTCOMES FOLLOWING ROBOT ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM

AUA VUI 2018 Presentations

Presentor	Presentation
Sohrab Arora	MP48-18 WHAT IS THE HOSPITAL VOLUME THRESHOLD TO OPTIMIZE MAJOR INPATIENT COMPLICATION RATE AFTER ROBOTIC PARTIAL NEPHRECTOMY?
Akshay Sood	PD25-03 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA VERSUS OPEN KIDNEY TRANSPLANTATION FOR PATIENTS WITH END STAGE RENAL DISEASE: A TWO-ARM STUDY (IDEAL PHASE 2B)
Akshay Sood	MP87-16 EFFECT OF RACE ON THE RISK OF METASTASIS AND MORTALITY IN PATIENTS EXPERIENCING EARLY BIOCHEMICAL RECURRENCE FOLLOWING ROBOTIC RADICAL PROSTATECTOMY
Mustafa Deebajah	MP14-14 PROPENSITY SCORE MATCHED STUDY TO EXAMINE THE EFFECT OF RACE ON THE NUMBER OF LESIONS SUSPICIOUS FOR PROSTATE CANCER DETECTED THROUGH MAGNETIC RESONANCE IMAGING OF THE PROSTATE
Richard Thompson	MP14-16 THE CHARACTERISTICS OF PROSTATE CANCER ON FINAL PATHOLOGY IN MEN UNDERGO RADICAL PROSTATECTOMY WITH A NEGATIVE MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING
Firas Abdollah	MP42-12 TESTING THE EXTERNAL VALIDITY OF EORTC 30904 COMPARING OVERALL SURVIVAL AFTER RADICAL NEPHRECTOMY VS NEPHRON SPARING SURGERY IN CONTEMPORARY NORTH AMERICAN PATIENTS WITH RENAL CELL CANCER
Alex Borchert	MP67-13 INCIDENCE OF PEYRONIE'S DISEASE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY IN MEN WITH POST-OPERATIVE SUPRAPUBIC CATHETERS AND NO URETHRAL FOLEY CATHETERS
Firas Abdollah	MP22-05 TESTING THE IMPACT OF ADJUVANT RADIOTHERAPY (ART) AFTER RADICAL PROSTATECTOMY (RP) ON OVERALL MORTALITY (OM) IN PROSTATE CANCER PATIENTS WITH PATHOLOGICALLY NODE POSITIVE DISEASE: A NATIONWIDE ANALYSIS
Sean A Fletcher	MP53-01 CONTEMPORARY NATIONAL TRENDS IN LOCALIZED PROSTATE CANCER RISK PROFILE AT DIAGNOSIS
Tyler R McClintock	PD38-06 CONTEMPORARY TRENDS IN UTILIZATION OF RADICAL PROSTATECTOMY
Firas Abdollah	MP05-05 ASSESSING THE EXTERNAL VALIDITY OF THE UPDATED PROSTATE CANCER(PCA) INTERVENTION VERSUS OBSERVATION TRIAL (PIVOT)
Tyler R McClintock	MP13-19 TESTOSTERONE REPLACEMENT THERAPY IS ASSOCIATED WITH INCREASED INCIDENCE OF UROLITHIASIS
Alexander P Cole	MP41-11 IMPACT OF HIGH VOLUME SURGICAL CARE ON MEDIAN OVERALL SURVIVAL FOR LOCALIZED BLADDER CANCER
Daniel Pucheril	MP77-18 IMPACT OF SEXUAL ORIENTATION ON CONTEMPORARY RATES OF PROSTATE CANCER SCREENING
MP82-02 SHARED DECISION MAKING FOR PROSTATE CANCER SCREENING: REALITY OR FARCE?
Daniel Pucheril	MP82-03 IMPACT OF LATE MEDICAID EXPANSION ON PROSTATE CANCER SCREENING
Philipp Gild	PD11-09 RACIAL DISPARITIES IN QUALITY OF CARE AND OVERALL SURVIVAL AMONG MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY: A NATIONAL CANCER DATABASE ANALYSIS
Nicholas Von Landenberg	MP11-10 NEOADJUVANT ANDROGEN DEPRIVATION THERAPY PRIOR TO RADICAL PROSTATECTOMY: RECENT TRENDS IN UTILIZATION AND ASSOCIATION WITH POSTOPERATIVE SURGICAL MARGIN STATUS
Sean A Fletcher
Marco Bandini	MP17-07 INCREASING RATE OF NON-INTERVENTIONAL TREATMENT MANAGEMENT IN LOCALIZED PROSTATE CANCER CANDIDATES FOR ACTIVE SURVEILLANCE
Nazareno Suardi	MP21-09 WHO DIES FROM PROSTATE CANCER? A COMPREHENSIVE ANALYSIS OF A LARGE SERIES OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY WITH LONG-TERM FOLLOW-UP
Michele Marchioni	PD07-06 COMPARISON OF PARTIAL VS. RADICAL NEPHRECTOMY EFFECT ON OTHER CAUSE MORTALITY, CANCER SPECIFIC MORTALITY AND 30-DAY MORTALITY IN PATIENTS OLDER THAN 75 YEARS
Giorgio Gandaglia	MP53-17 WHERE DO WE MISS EXTRACAPSULAR EXTENSION AT MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE?
Emanuele Zaffuto	PD38-01 WHICH PATIENTS WITH LOW-RISK PROSTATE CANCER ARE STILL RECEIVING RADICAL PROSTATECTOMY? IMPACT OF PATIENT SELECTION ON INVERSE STAGE MIGRATION AT TWO TERTIARY REFERRAL CENTERS

AUA VUI 2017 Presentations

Presentor	Presentation
Mani Menon	MP97-04 URINARY CONTINENCE, SEXUAL FUNCTION AND BIOCHEMICAL RECURRENCE 12 MONTHS FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A RANDOMIZED CONTROLLED STUDY COMPARING THE ‘BOCCIARDI’ AND ‘MENON’ TECHNIQUES
Sohrab Arora	MP06-05 LEARNING CURVE OF A NEW SURGICAL PROCEDURE: EXPERIENCE FROM A NEW CENTER ADOPTING ROBOTIC KIDNEY TRANSPLANT.
Gregory Auffenberg	PD18-02 MEASURING TO IMPROVE: PATIENT REPORTED OUTCOMES DURING THE FIRST YEAR AFTER PROSTATECTOMY IN A STATEWIDE COLLABORATIVE
Jesse Sammon	PD32-05 PROSTATE CANCER SCREENING: EFFECT OF EARLY MEDICAID EXPANSION
Daniel Pucheril	MP69-01 ANTIMUSCARINIC USE IN THE ELDERLY: A POISONED APPLE?
Deepansh Dalela	PD03-06 CONTEMPORARY TRENDS IN INCIDENCE OF METASTATIC PROSTATE CANCER AMONG US MEN: RESULTS FROM NATIONWIDE ANALYSES
Stephen Ryan	MP04-20 THE ASSOCIATION BETWEEN MORTALITY AND DISTANCE TO TREATMENT FACILITY IN PATIENTS WITH INVASIVE BLADDER CANCER
Jesse Sammon	PD58-12 PSA SCREENING AT THE INTERSECTION OF POLITICS AND POLICY
Naveen Kachroo	MP92-07 TAKE ‘NOTES’: IDENTIFYING DRIVERS OF 30 DAY READMISSION AFTER RADICAL PROSTATECTOMY
Malte W. Vetterlein	PD18-07 THE IMPACT OF TRAVEL DISTANCE TO THE TREATMENT FACILITY ON OVERALL MORTALITY IN PROSTATE CANCER PATIENTS: EVIDENCE FROM THE NATIONAL CANCER DATA BASE
Haider Rahbar	PD43-11 LACK OF SUSTAINABLE RESPONSE TO THE 2012 UNITED STATES PREVENTIVE SERVICES TASK FORCE (USPSTF) RECOMMENDATION AGAINST PROSTATE CANCER (PCA) SCREENING
Tarun Jindal	PD51-05 SURVIVAL ASSOCIATED WITH RADICAL PROSTATECTOMY VERSUS RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER: A CONTEMPORARY, NATIONWIDE OBSERVATIONAL ANALYSIS
Björn Löppenberg	PD47-08 VARIATION AND TRENDS IN PROSTATE CANCER CARE AT COMMISSION ON CANCER DESIGNATED FACILITIES
Philipp Gild	MP28-08 REFUSAL OF PROSTATE-SPECIFIC ANTIGEN TESTING IN THE UNITED STATES
Thomas Seisen	PD57-03 ASSESSMENT OF THE ECOLOGICAL ASSOCIATION BETWEEN TOBACCO SMOKING EXPOSURE AND BLADDER CANCER INCIDENCE OVER THE PAST HALF-CENTURY IN THE UNITED STATES
Deepansh Dalela	PD72-02 GENOMIC CLASSIFIER AUGMENTS THE ROLE OF PATHOLOGICAL FEATURES IN IDENTIFYING OPTIMAL CANDIDATES FOR ADJUVANT RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER: DEVELOPMENT AND INTERNAL VALIDATION OF A MULTIVARIABLE PROGNOSTIC MODEL
Deepansh Dalela	PD15-04 A RANDOMIZED CONTROLLED TRIAL EXAMINING THE IMPACT OF THE RETZIUS- SPARING APPROACH ON EARLY URINARY CONTINENCE RECOVERY AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY
Nicholas Von Landenberg	MP22-18 CONTEMPORARY INCIDENCE AND EPIDEMIOLOGIC TRENDS OF BRAIN METASTASES AT RENAL CELL CARCINOMA DIAGNOSIS
Thomas Seisen	MP53-18 EFFICACY OF LOCAL TREATMENT IN PROSTATE CANCER PATIENTS WITH CLINICALLY PELVIC LYMPH NODE-POSITIVE DISEASE AT INITIAL DIAGNOSIS
Thomas Seisen	PD62-02 ADJUVANT CHEMOTHERAPY VS. OBSERVATION FOLLOWING RADICAL CYSTECTOMY FOR PT3-4 AND/OR PN+ UROTHELIAL CARCINOMA OF THE BLADDER PREVIOUSLY TREATED WITH NEOADJUVANT CHEMOTHERAPY
Malte W. Vetterlein	MP34-11 NEOADJUVANT CHEMOTHERAPY PRIOR TO RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY
Nawar Hanna	PD67-09 COMPARATIVE EFFECTIVNESS OF ROBOT-ASSISTED VS. OPEN RADICAL CYSTECTOMY
Julian Hanske	MP91-04 ADVERSE EFFECTS OF TESTOSTERONE REPLACEMENT THERAPY FOR MEN, A MATCHED COHORT STUDY
Björn Löppenberg	PD28-06 VARIATION IN THE USE OF ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
David Friedlander	PD10-10 RACIAL DISPARITIES IN DELIVERING DEFINITIVE THERAPY FOR INTERMEDIATE-HIGH RISK LOCALIZED PROSTATE CANCER: THE IMPACT OF FACILITY FEATURES AND SOCIOECONOMIC CHARACTERISTICS
Christian P Meyer	PD27-11 COMPARATIVE EFFECTIVENESS OF TRANSURETHRAL RESECTION TECHNIQUES FOR BENIGN PROSTATIC HYPERPLASIA – ANALYSIS OF AN ALL PAYER INPATIENT DISCHARGE DATABASE
Christian P Meyer	MP55-17 ASSESSMENT OF METASTASECTOMY COMPLICATIONS IN RENAL CELL CARCINOMA
Thomas Seisen	PD62-01 COMPARATIVE EFFECTIVENESS OF SELECTIVE ADJUVANT VERSUS SYSTEMATIC NEOADJUVANT CHEMOTHERAPY-BASED STRATEGY FOR MUSCLE- INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
Malte W. Vetterlein	MP34-19 EFFECT OF HISTOLOGICAL VARIANTS ON THE OUTCOMES OF RADICAL CYSTECTOMY FOR NON-METASTATIC MUSCLE-INVASIVE URINARY BLADDER CANCER
Michael E Zavaski	PD05-11 CONTEMPORARY PERCEPTIONS OF HUMAN PAPILLOMAVIRUS AND PENILE CANCER – PERSPECTIVES FROM A NATIONAL SURVEY
Thomas Seisen	PD62-12 COMPARATIVE EFFECTIVENESS OF TRIMODAL THERAPY VERSUS RADICAL CYSTECTOMY FOR LOCALIZED MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
Paul May	MP92-05 CALCULATING SURGICAL TIME FOR ROBOT-ASSISTED RADICAL CYSTECTOMY BASED ON PATIENT RELATED METRICS & INSTITUTIONAL EXPERIENCE: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM

AUA VUI 2016 Presentations

<td">MP37-02 INFORMED DECISION-MAKING FOR PROSTATE-SPECIFIC ANTIGEN SCREENING </td">

Presentor	Presentation
Naveen Kachroo	PD03-10 APPLICABILITY OF EPSTEIN’S CRITERIA FOR ACTIVE SURVEILLANCE IN A CONTEMPORARY US COHORT UNDERGOING ROBOTIC PROSTATECTOMY
Akshay Sood	MP29-07 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA: RESULTS FROM A PROSPECTIVE TWO-ARM NON-RANDOMIZED CONTROLLED TRIAL (IDEAL PHASE 2B)
Firas Abdollah	PD43-12 URINARY CONTINENCE OUTCOMES AFTER RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A PROSPECTIVE, NON-RANDOMIZED, IDEAL STAGE 2B (EXPLORATION) STUDY.
Mohsin Jamal	MP79-12 CLINICAL SIGNIFICANCE OF PERCENTAGE OF GLEASON PATTERN 4 IN GLEASON SCORE 7 PROSTATE CANCER AT RADICAL PROSTATECTOMY
Akshay Sood	MP80-06 INTRAOPERATIVE BIMANUAL EXAMINATION AND FROZEN-SECTION ANALYSIS DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A NOVEL TECHNIQUE FOR REDUCING POSITIVE SURGICAL MARGINS
Firas Abdollah	PD15-01 THE IMPACT OF 2011 UNITED STATES PREVENTIVE SERVICES TASK FORCE PANEL UPDATE ON PSA SCREENING PRACTICE: A NATIONWIDE, AND STATE-BY-STATE LEVEL ANALYSES.
Firas Abdollah	MP21-05 TEMPORAL TRENDS IN PROSTATE CANCER RISK GROUP STRATIFICATION FOLLOWING THE 2008 UNITED STATES PREVENTIVE SERVICES TASK FORCE RECOMMENDATIONS
Jesse Sammon	MP21-08 DETERMINANTS OF PROSTATE SPECIFIC ANTIGEN SCREENING AMONG BLACK MEN IN THE UNITED STATES IN THE CONTEMPORARY ERA
Jesse Sammon	MP21-11 AGE DEPENDENT VARIATION IN THE EFFECT OF PHYSICIAN RECOMMENDATIONS TO UNDERGO PROSTATE SPECIFIC ANTIGEN (PSA) SCREENING FOLLOWING THE UNITED STATES PREVENTIVE SERVICES TASK FORCE 2012 STATEMENT AGAINST PSA SCREENING.
Hanhan Li	MP25-08 DETERMINANTS OF PROSTATE CANCER SCREENING IN ASIAN AMERICANS
Deepansh Dalela	PD37-01 CONTEMPORARY TRENDS IN TREATMENT PATTERNS FOR MEN DIAGNOSED WITH CLINICALLY LOCALIZED PROSTATE CANCER
Firas Abdollah	PD37-03 IS THE PROSTATE CANCER INTERVENTION VERSUS OBSERVATION TRIAL REFLECTIVE OF THE CONTEMPORARY US POPULATION DIAGNOSED WITH PROSTATE CANCER? RESULTS FROM THE NATIONAL CANCER DATABASE 2004-2011
Björn Löppenberg	MP65-20 SLING PROCEDURES FOR FEMALE STRESS INCONTINENCE: DOES SURGICAL SPECIALTY MATTER?
Deepansh Dalela	MP39-14 IMPACT OF THE 2012 UNITED STATES PREVENTIVE SERVICES TASK FORCE RECOMMENDATION AGAINST PROSTATE SPECIFIC ANTIGEN SCREENING ON PROSTATE CANCER RISK GROUP STRATIFICATION
Björn Löppenberg	MP50-12 THE IMPACT OF LOCAL TREATMENT ON OVERALL MORTALITY IN PATIENTS DIAGNOSED WITH PRIMARY METASTATIC PROSTATE CANCER
Christian P Meyer	MP21-10 THE IMPACT OF MEDICARE ELIGIBILITY ON PROSTATE CANCER SCREENING BEHAVIORS
Alexander P Cole	PI-04 SURGEON AND HOSPITAL VARIATION IN THE COSTS OF ROBOT-ASSISTED RADICAL PROSTATECTOMY IN THE UNITED STATES
Jeffrey Leow	PD39-07 SURGEON VARIATION IN THE COSTS OF RADICAL CYSTECTOMY
Nawar Hanna
Christian P Meyer	MP63-06 RACIAL DISPARITIES IN QUALITY METRICS OF MUSCLE INVASIVE BLADDER CANCER
Michael E Zavaski	PD15-03 DIFFERENCES IN PROSTATE SPECIFIC ANTIGEN TESTING AMONG UROLOGISTS AND PRIMARY CARE PROVIDERS IN THE UNITED STATES FOLLOWING THE 2011 USPSTF RECOMMENDATIONS
Christian P Meyer	MP69-11 MINIMALLY INVASIVE VS. OPEN RADICAL PROSTATECTOMY: AN ANALYSIS OF 30-DAY POSTOPERATIVE COMPLICATIONS, UNPLANNED READMISSIONS, AND MORTALITY
Firas Abdollah	MP80-20 LONG-TERM FUNCTIONAL OUTCOMES OF PROSTATE CANCER PATIENTS TREATED WITH ROBOT-ASSISTED RADICAL PROSTATECTOMY
Christian P Meyer	PD04-05 TRENDS OF METASTASECTOMY FOR METASTATIC RENAL CELL CARCINOMA AND THEIR IMPACT ON OVERALL SURVIVAL
Firas Abdollah	MP80-02 LATE RECOVERY OF ERECTILE FUNCTION IN MEN TREATED WITH ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: A NOVEL NOMOGRAM DEVELOPMENT AND VALIDATION
Ahmed A Hussein	MP06-09 ASSESSMENT OF PATIENT CENTERED, CANCER SPECIFIC QUALITY METRICS IN ROBOT-ASSISTED RADICAL CYSTECTOMY: HOW DID WE PERFORM?

AUA VUI 2015 Presentations

Presentor	Presentation
Vijayalakshmi Thamilselvan	MP46-20 CARMUSTINE AND SELENITE COMBINATION THERAPY EFFECTIVELY INHIBITS CASTRATION RESISTANT PROSTATE CANCER IN PRECLINICAL MODELS
Akshay Sood	MP79-14 MINIMALLY INVASIVE KIDNEY TRANSPLANTATION: PERIOPERATIVE CONSIDERATIONS AND KEY 6-MONTH OUTCOMES
Alexander P Cole	PD31-06 TEMPORAL TRENDS AND PREDICTORS OF THE RECEIPT OF ADEQUATE LYMPHADENECTOMY AT RADICAL CYSTECTOMY FOR BLADDER CANCER
Jesse Sammon	PD6-12 DIMINISHING RETURNS OF ROBOTIC DIFFUSION: COMPLICATIONS FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY
Jesse Sammon	PD38-01 HETEROGENEITY OF RECOMMENDED PSA SCREENING PRACTICES IN MEN AGED 55-69 IN THE UNITED STATES
Akshay Sood	MP79-04 NATIONAL TRENDS AND RACIAL DISPARITIES IN LIVING KIDNEY DONATION: ANALYSIS OF THE UNITED NETWORK OF ORGAN SHARING 1998-2011
Jesse Sammon	MP77-13 DEFICIENCIES IN PSA SCREENING PRACTICES IN BLACK MEN AGED 55-69 IN THE UNITED STATES
Akshay Sood	PD13-03 ROBOTIC ANATROPHIC NEPHROLITHOTOMY: IDEA, DEVELOPMENT, EXPLORATION, ASSESSMENT AND LONG-TERM MONITORING (IDEAL) PHASE 0 STUDY
Laura Favazza	MP53-13 IS DOMINANT TUMOR NODULE SIZE A SIGNIFICANT PREDICTOR OF ADVERSE OUTCOME IN PROSTATE CANCER? A STUDY OF 487 WHOLE MOUNT RADICAL PROSTATECTOMY CASES.
Jesse Sammon	MP87-05 INCREASING USE OF HOSPICE SERVICES FOR METASTATIC PROSTATE CANCER MODERATES THE ECONOMIC BURDEN OF HOSPITAL ADMISSIONS FOR METASTATIC PROSTATE CANCER
Jesse Sammon	MP64-13 HEALTHCARE-ASSOCIATED INFECTIONS FOLLOWING CYSTECTOMY: ROOM FOR IMPROVEMENT
Jesse Sammon	MP73-19 PRIMARY ANDROGEN DEPRIVATION THERAPY INCREASES ALL CAUSE MORTALITY IN POPULATIONS MATCHED BY COMORBIDITY ADJUSTED LIFE EXPECTANCY AND DISEASE RISK
Firas Abdollah	MP78-19 PREDICTING PATHOLOGIC OUTCOMES IN PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A PREOPERATIVE NOMOGRAM
Akshay Sood	MP9-14 POSTOPERATIVE SEPSIS PREDICTION IN PATIENTS UNDERGOING MAJOR CANCER SURGERY
Daniel Pucheril	MP77-10 THE INFLUENCE OF PHYSICIAN RECOMMENDATION ON PSA SCREENING
Firas Abdollah	MP87-14 ADJUVANT RADIOTHERAPY IN PROSTATE CANCER PATIENTS TREATED WITH SURGERY: THE IMPACT OF AGE AND TUMOR CHARACTERISTICS
Akshay Sood	MP65-19 AN EVALUATION OF THE TIMING OF SURGICAL COMPLICATIONS FOLLOWING RADICAL CYSTECTOMY
Christian P Meyer	MP67-09 PREDICTORS OF WOUND DEHISCENCE IN A PROSPECTIVE DATASET OF 2,556 CYSTECTOMIES
Marianne Schmid	MP24-20 CAUSES OF HOSPITAL READMISSIONS AFTER UROLOGIC CANCER SURGERY
Jeffrey Leow	MP32-08 READMISSIONS AFTER MAJOR UROLOGIC CANCER SURGERY
Akshay Sood	MP54-07 INCIDENCE, ADMISSION RATES AND ECONOMIC BURDEN OF PEDIATRIC EMERGENCY DEPARTMENT VISITS FOR URINARY TRACT INFECTION
Firas Abdollah	MP60-01 PREVALENCE OF NON-RECOMMENDED SCREENING FOR PROSTATE CANCER AND BREAST CANCER IN THE UNITED STATES
Christian P Meyer	MP67-05 THE IMPACT OF PREOPERATIVE HYPOALBUMINEMIA ON PERIOPERATIVE OUTCOMES AFTER RADICAL CYSTECTOMY IN 1,262 PATIENTS
Daniel Pucheril	MP77-12 CONTEMPORARY PATTERNS OF SELF-REPORTED PSA SCREENING IN U.S. VETERANS
Nicola Fossati	MP82-07 DOES LOCAL TREATMENT OF THE PRIMARY TUMOR IMPROVE SURVIVAL OF METASTATIC PROSTATE CANCER PATIENTS? RESULTS FROM A POPULATION-BASED STUDY.
James O Peabody	PD30-05 WISDOM OF THE CROWDS: USE OF CROWDSOURCING TO ASSESS SURGICAL SKILL OF ROBOT-ASSISTED RADICAL PROSTATECTOMY IN A STATEWIDE SURGICAL COLLABORATIVE
Marianne Schmid	PD30-09 THE EFFECT OF ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER ON CARDIOVASCULAR MORBIDITY ACCORDING TO LIFE EXPECTANCY
Akshay Sood	;MP59-03 AN EVALUATION OF THE TIMING OF SURGICAL COMPLICATIONS FOLLOWING NEPHRECTOMY
Firas Abdollah	MP73-11 ANDROGEN DEPRIVATION THERAPY AND INCREASED NON-CANCER MORTALITY IN PROSTATE CANCER PATIENTS: ANALYSIS OF THE NUMBER NEEDED TO TREAT
Nicola Fossati	MP24-06 THE IMPACT OF INSURANCE STATUS ON TUMOR CHARACTERISTICS AND TREATMENT SELECTION IN CONTEMPORARY PROSTATE CANCER PATIENTS
Marianne Schmid	PD30-12 RACIAL DISPARITIES IN THE SURGICAL CARE OF LOCALIZED PROSTATE CANCER
Akshay Sood	MP9-08 IMPACT OF SMOKING ON PERIOPERATIVE OUTCOMES AFTER MAJOR UROLOGIC SURGERY
Nicola Fossati	PD30-03 PREDICTING UNFAVORABLE PROSTATE CANCER IN ACTIVE SURVEILLANCE CANDIDATES TREATED WITH RADICAL PROSTATECTOMY: A POPULATION-BASED STUDY
Nicola Fossati	MP78-01 CONTEMPORARY MANAGEMENT OF PROSTATE CANCER PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: A POPULATION-BASED STUDY.
Firas Abdollah	MP4-14 LONG-TERM CANCER CONTROL OUTCOMES IN PROSTATE CANCER (PCA) PATIENTS TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP): A MULTI-INSTITUTIONAL DATABASE ANALYSIS.
Firas Abdollah	PD30-08 CANCER-CONTROL OUTCOMES IN PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER (PCA) TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP): A MULTI-INSTITUTIONAL DATABASE ANALYSIS
Firas Abdollah	MP62-01 FUNCTIONAL OUTCOMES IN PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER (PCA) TREATED WITH ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP)
Firas Abdollah	MP82-16 LONG-TERM CLINICAL RECURRENCE RATE IN PROSTATE CANCER (PCA) PATIENTS WITH ADVERSE PATHOLOGICAL CHARACTERISTICS AT ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP)
Firas Abdollah	MP82-17 ONCOLOGICAL OUTCOMES IN PN1 PROSTATE CANCER (PCA) PATIENTS TREATED WITH ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP)

AUA VUI 2014 Presentations

Presentor	Presentation
Khurshid Ghani	V11-01 RETROPERITONEAL ROBOTIC PARTIAL NEPHRECTOMY: A STEP-BY-STEP GUIDE
Vijayalakshmi Thamilselvan	MP20-14 UNCOUPLED ENDOTHELIAL NITRIC OXIDE SYNTHASE CONTRIBUTES TO OXALATE-INDUCED OXIDATIVE CELL INJURY IN RENAL EPITHELIAL CELLS: EFFECT OF ANTIOXIDANTS
Craig G Rogers	V7-12 EVOLUTION OF REGIONAL HYPOTHERMIA IN ROBOTIC KIDNEY SURGERY
Mahendra Bhandari	V7-06 RECIPIENT ROBOT ASSISTED KIDNEY TRANSPLANT LEARNING STEPS: FRAME-BY-FRAME VIDEO ANALYSIS
Akshay Sood	PD30-02 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA: RESULTS FROM A PROSPECTIVE TWO-ARM NON-RANDOMIZED CONTROLLED TRIAL (IDEAL PHASE 2B)
Wooju Jeong	MP72-10 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA: EVOLUTION OF A NOVEL PROCEDURE UTILIZING THE IDEAL GUIDELINES (IDEAL PHASE 0 AND 1)
Wooju Jeong	V9-03 ROBOTIC KIDNEY TRANSPLANTATION WITH REGIONAL HYPOTHERMIA: A STEP-BY-STEP DESCRIPTION OF THE VUI-MEDANTA TECHNIQUE (IDEAL PHASE 2A)
Briony Varda	PD7-06 NATIONAL RATES AND RISK FACTORS FOR STENT FAILURE IN PATIENTS WITH OBSTRUCTED, INFECTED UPPER TRACT STONES
Tudor Borza	MP2-16 MORBIDITY AND MORTALITY AFTER BENIGN PROSTATIC HYPERPLASIA SURGERY: DATA FROM THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM
Syed Johar Raza	MP61-10 LONG-TERM SURVIVAL OUTCOMES OF ROBOT-ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM
Abd-El-Rahman	PD5-11 TRENDS AND OUTCOMES IN PEDIATRIC SICKLE CELL-ASSOCIATED PRIAPISM
Ramesh Kumar	MP54-07 ROBOTIC PARTIAL NEPHRECTOMY IN PATIENTS WITH BASELINE CHRONIC KIDNEY DISEASE: A MULTICENTER PROPENSITY SCORE MATCHED ANALYSIS
Giorgio Gandaglia	MP51-19 COMPARATIVE EFFECTIVENESS OF ROBOTIC-ASSISTED AND OPEN RADICAL PROSTATECTOMY IN THE “POST-LEARNING CURVE” ERA
Ariella A Friedman	MP3-09 NATIONAL TRENDS AND DISPARITIES IN THE UTILIZATION OF INPATIENT HYPOSPADIAS SURGERY

AUA VUI 2013 Presentations

Presentor	Presentation
Vijayalakshmi Thamilselvan	2086 OXALATE-INDUCED NADPH OXIDASE ACTIVATION IN RENAL EPITHELIAL CELLS: ROLE OF UPSTREAM MEDIATORS
Craig G Rogers	V1077 INTRACORPOREAL COOLING AND EXTRACTION TECHNIQUE OF ROBOTIC PARTIAL NEPHRECTOMY: RECAPITULATING THE OPEN APPROACH
Khurshid R Ghani	1305 OUTCOMES FOR OPEN AND MINIMALLY INVASIVE PARTIAL NEPHRECTOMY SINCE THE INTRODUCTION OF ROBOTIC PARTIAL NEPHRECTOMY: RESULTS FROM THE NATIONWIDE INPATIENT SAMPLE
Wooju Jeong	845 BIMANUAL EXAMINATION OF RETRIEVED SPECIMEN DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A NOVEL TECHNIQUE FOR REDUCING THE POSTIVE SURGICAL MARGIN
Syed Johar Raza	1564 CONSTRUCT VALIDATION OF THE FUNDAMENTAL SKILLS OF ROBOTIC SURGERY (FSRS) CURRICULUM
Ashirwad Chowriappa	886 DEVELOPMENT & VALIDATION OF A COMPOSITE GRADING & SCORING SYSTEM FOR ROBOT-ASSISTED SURGICAL TRAINING — THE ROBOTIC SKILLS ASSESSMENT SCALE
Wooju Jeong	V2156 BIMANUAL EXAMINATION OF RETRIEVED SPECIMEN AND REGIONAL HYPOTHERMIA DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY
Khurshid R Ghani	69 THE BURDEN OF HEMATURIA IN THE UNITED STATES: ESTIMATES FROM THE NATIONWIDE EMERGENCY DEPARTMENT SAMPLE
Jesse Sammon	362 ROBOT-ASSISTED VS. OPEN RADICAL PROSTATECTOMY: A COMPARISON OF OUTCOMES ACROSS PROCEDURE TYPE AND VOLUME QUARTILE
Shyam Sukumar	423 EMERGENCY ROOM VISITS IN PATIENTS WITH METASTATIC PROSTATE CANCER
Khurshid R Ghani	1977 TRENDS IN UTILIZATION AND OUTCOMES FOR PERCUTANEOUS NEPHROLITHOTOMY IN THE UNITED STATES
Khurshid R Ghani	1981 TRENDS IN SURGERY FOR UPPER URINARY TRACT STONES IN THE UNITED STATES: 1999-2009
Khurshid R Ghani	1289 ACUTE IMAGING FOR HEMATURIA IN THE UNITED STATES: COSTS AND PREDICTORS FROM THE NATIONWIDE EMERGENCY DEPARTMENT SAMPLE
Jesse Sammon	1545 TRENDS IN UTILIZATION AND COMPARATIVE OUTCOMES FOR INFECTED UPPER URINARY TRACT STONES IN THE UNITED STATES: PCN VS. STENT
Hanhan Li	1050 UTILIZATION AND PERI-OPERATIVE OUTCOMES OF ROBOT-ASSISTED AND OPEN VAGINAL VAULT SUSPENSION
Jesse Sammon	2120 LIVE DONOR NEPHRECTOMY VS. KIDNEY TRANSPLANTS IN MINORITY POPULATIONS: A POPULATION BASED ANALYSIS OF TRENDS
Khurshid R Ghani	721 IT'S THE WEEKEND! INCREASED MORTALITY IN METASTATIC PROSTATE CANCER PATIENTS VISITING THE EMERGENCY DEPARTMENT IN THE WEEKEND VS. WEEKDAY
Jesse Sammon	1062 SOCIOECONOMIC TRENDS AND UTILIZATION IN THE EMERGENCY DEPARTMENT TREATMENT OF URINARY TRACT INFECTIONS
Khurshid Guru	1764 COMPARATIVE ONCOLOGIC EFFECTIVENESS BETWEEN ROBOT-ASSISTED AND OPEN RADICAL CYSTECTOMY

AUA VUI 2012 Presentations

Presentor	Presentation
Vijayalakshmi Thamilselvan	2072 ROLE OF REACTIVE OXYGEN SPECIES AND CARDIOLIPIN PEROXIDATION IN OXALATE-INDUCED RENAL MITOCHONDRIAL DYSFUNCTION: EFFECT OF ANTIOXIDANTS
Chris Wambi	1335 ONCOLOGIC OUTCOMES OF ROBOT-ASSISTED RADICAL PROSTATECTOMY IN YOUNG MEN
Quoc-Dien Trinh	1459 CLINICAL AND PATHOLOGIC FEATURES OF PROSTATE CANCER WITH PROSTATIC-SPECIFIC ANTIGEN (PSA) LESS THAN 2.5 NG/ML: A STUDY OF 209 CASES
Khurshid R Ghani	999 CAN QUANTITATION AND SUB-CATEGORIZATION OF EXTRAPROSTATIC EXTENSION AT RADICAL PROSTATECTOMY PREDICT BIOCHEMICAL RECURRENCE?
Michael Marean	358 CREATION OF A PREOPERATIVE NOMOGRAM THAT INCLUDES ENDORECTAL MRI ACCURATELY PREDICTS NON ORGAN-CONFINED PROSTATE CANCER
Khurshid R Ghani	V1033 ROBOT-ASSISTED RETROPERITONEAL LYMPH NODE DISSECTION MODIFIED NERVE-SPARING LEFT SIDED TEMPLATE
Quoc-Dien Trinh	V405 ENUCLEATION TECHNIQUES FOR CHALLENGING ROBOT-ASSISTED PARTIAL NEPHRECTOMY CASES
Jay Jhaveri	V1027 ROBOT-ASSISTED SIMPLE PROSTATECTOMY
Wooju Jeong	V1890 ROBOT-ASSISTED PARTIAL CYSTECTOMY FOR BLADDER CANCER OF A BLADDER DIVERTICULUM
Khurshid R Ghani	V1891 INTRACORPOREAL ILEAL CONDUIT URINARY DIVERSION
Jan Schmitges	1685 HIGHER PERIOPERATIVE MORBIDITY AND IN-HOSPITAL MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE UNDERGOING NEPHRECTOMY FOR NON-METASTATIC KIDNEY CANCER: A POPULATION-BASED ANALYSIS
Jay Jhaveri	V242 ROBOT-ASSISTED REPAIR OF RECURRENT VESICOVAGINAL FISTULA
Quoc-Dien Trinh	687 DIFFERENCES IN PERIOPERATIVE OUTCOMES BETWEEN AFRICAN AMERICAN AND CAUCASIAN PATIENTS AFTER RADICAL PROSTATECTOMY
Khurshid R Ghani	1602 A POPULATION-BASED ASSESSMENT OF OUTCOMES AFTER RADICAL CYSTECTOMY IN OCTOGENARIANS
Khurshid R Ghani	693 IMPACT OF POSTERIOR RECONSTRUCTION OF DENONVILLIER'S MUSCULOFASCIAL PLATE ON ANASTOMOTIC LEAKAGE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY A PROPENSITY-SCORE MATCHED ANALYSIS
Khurshid R Ghani	1466 PREOPERATIVE NOMOGRAM PREDICTING ERECTILE FUNCTION TWO YEARS AFTER RADICAL PROSTATECTOMY
Quoc-Dien Trinh	1284 THE EFFECT OF GENDER ON NEPHRECTOMY PERIOPERATIVE OUTCOMES: A NATIONAL SURVEY
Quoc-Dien Trinh	688 THE EFFECT OF HOSPITAL VS. SURGICAL VOLUME ON OUTCOMES AFTER RADICAL PROSTATECTOMY A HEAD-TO-HEAD COMPARISON USING DECISION-CURVE ANALYSES
Quoc-Dien Trinh	1787 THE EFFECT OF NODAL CODING SCHEMES ON CANCER-SPECIFIC MORTALITY AFTER CYTOREDUCTIVE NEPHRECTOMY
Quoc-Dien Trinh	1336 THE IMPACT OF HOSPITAL VOLUME, RESIDENCY AND FELLOWSHIP TRAINING ON COMPLICATIONS AFTER RADICAL PROSTATECTOMY
Quoc-Dien Trinh	1338 PERIOPERATIVE OUTCOMES OF ROBOT-ASSISTED RADICAL PROSTATECTOMY VS. OPEN RADICAL PROSTATECTOMY
Quoc-Dien Trinh	426 DISPARITIES IN THE UTILIZATION OF PARTIAL NEPHRECTOMY IN THE UNITED STATES A CASE FOR CONCERN?
Quoc-Dien Trinh	1103 ROBOT-ASSISTED VS. LAPAROSCOPIC PARTIAL NEPHRECTOMY UTILIZATION PATTERNS AND PERIOPERATIVE OUTCOMES IN THE UNITED STATES
Kamran Ahmed	1161 COMPARISON OF OUTCOMES BETWEEN INTRA-CORPOREAL AND EXTRA-CORPOREAL URINARY DIVERSION AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY – THE IRCC RESULTS
Matthew H Hayn	1407 IS ROBOT-ASSISTED RADICAL CYSTECTOMY EFFECTIVE FOR T3 BLADDER CANCER? RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM

EUA VUI Presentations

EAU VUI 2023 Presentations

Presentor	Presentation
Matt Davis	#AM23-1737 Frequentist and Bayesian Analysis of Potential Adverse Events of the COVID-19 Immunization
Matt Davis	#AM23-3353 Baseline PSA levels in midlife & future development of lethal prostate cancer: A diverse North American cohort analysis
Matt Davis	#AM23-4962 Racial disparities in future development of lethal prostate cancer based on PSA levels in midlife
Ivan Rakic	Evaluating the role of lymphvascular invasion as an indicator for adverse outcomes for patients with upper tract urothelial carcinoma and its histological subtypes
Ivan Rakic	The impact of histological subtypes on stage at presentation and overall survival of patients with upper tract urothelial carcinoma: A nationwide cohort analysis
Sohrab Arora	23-8647 Inpatient outcomes of radical nephroureterectomy (NU) for upper tract urothelial cancer (UTUC), with trends in utilization and impact of robotic surgery – National Inpatient Sample (NIS) analysis.
Sohrab Arora	Outcomes of Precision Prostatectomy procedure for localized prostate cancer, and step-by-step technique of single port transvesical Precision Prostatectomy
Nick Corsi	Testing the external validity of the pout III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort
Nick Corsi	Radical therapy for low-risk upper tract urothelial carcinoma (ROBUUST collaborative group)
Nick Corsi	Perioperative and Functional Outcomes of Greenlight 180-W Photovaporization in Large (>80 cc) Prostates: an Analysis from 7 Centers in the International Global Greenlight Group
Matt Davis	#AM23-3251 Industry Payments to Urologists Since the Sunshine Act
Matt Davis	#AM23-3261 Industry Payments to Urologists Since the COVID-19 Pandemic
Matt Davis	#AM23-3218 Evaluating The Impact of COVID-19 Pandemic on Prostate-Specific Antigen Testing in a North American Population: a health system-wide analysis
Matt Davis	#AM23-3219 Impact of Age and Race on Prostate-Specific Antigen Testing in Response to the COVID-19 Pandemic
Matt Davis	#AM23-3384 Is there a Role for Radical Cystectomy in treating patients with Metastatic Plasmacytoid Bladder Cancer Patients? A Nationwide cohort analysis.
Matt Davis	#AM23-3149 Impact of PSA testing pattern on cancer mortality among Black and White men diagnosed with prostate cancer: A large, urban health system cohort analysis
Matt Davis	#AM23-3276 Gender Gap in Industry Payments to Urologists
Taylor Malchow	Application and survival outcomes of landmark prostate specific antigen screening trial protocols in an urban healthcare system
Ivan Rakic	Is there a racial disparity in the outcomes of patients with non-metastatic upper urothelial carcinoma who are treated surgically? A north american nationwide analysis
Sohrab Arora	23-8612 Do saturation prostate biopsies provide additional clinically significant information in patients with MRI identified lesions sampled at the same time?
Sohrab Arora	Impact of a novel anterior suspension stitch on return of urinary continence after Robot-assisted Radical Prostatectomy with description of surgical technique
Sohrab Arora	23-8594 Inpatient outcomes of simultaneous radical cystectomy and nephroureterectomy in the United States: Retrospective analysis of the National Inpatient Sample
Sami Wilder

EAU VUI 2022 Presentations

Presentor	Presentation
Ivan Rakic	Evaluation of the utility of lymph-vascular invasion as an independent prognostic predictor of overall survival for patients with renal cell carcinoma that undergo nephrectomy
Mohit	Practice-level variation in rates positive surgical margins at partial nephrectomy: a MUSIC-KIDNEY analysis
Mohit	Reducing post-operative emergency department visits and readmissions after nephrectomy: an initial evaluation of the MUSIC-KIDNEY registry
Mohit	Evaluation of an uncomplicated recovery after nephrectomy: MUSIC-KIDNEY NOTES (Notable Outcomes and Trackable Events after Surgery)
Nick Corsi	Who is shaping the future of urology? A descriptive analysis of current urology residency program directors
Mohit	Assessing renal mass management of patients with increased comorbidities: Results from a statewide registry
Abdollah	The impact of Adjuvant chemotherapy on overall survival in patients with node-positive upper tract urothelial carcinoma (UTUC): improving precision in medicine with a risk-stratified approach.
AJ Piontkowski	Benefit of lymph node dissection in cn+ patients in the treatment of upper tract urothelial carcinoma: Analysis of ncdb registry
Nick Corsi	External validation of the Bladder Cancer Research Consortium (BCRC) nomogram for predicting survival after radical cystectomy

EAU VUI 2021 Presentations

Presentor	Presentation
Modonutti	P0861: A multi-trial based external validation of the Halabi nomogram in predicting the overall survival of metastatic castration-resistant prostate cancer patients
Marcus Jamil	P0640 Renal mass size and presence of synchronous lung metastasis at time of diagnosis: Implications for chest imaging
Sohrab Arora	Impact of preexisting opioid-dependence on morbidity, length of stay, and inpatient cost of urologic oncologic surgery
Nicholas Corsi	Recurrence-free survival following resection of low-grade, Non-Muscle-Invasive Urothelial Cancer (NMIBC): A Southwest Oncology Group (SWOG) S0337 post-hoc analysis
Nikola Rakic	P1217: Evaluation of the utility of lymphovascular invasion as a complementary or independent prognostic predictor of overall survival after radical prostatectomy
Volpe A	429: Robot-assisted partial nephrectomy for cT1b-T2 renal tumors: Perioperative outcomes from a large multicentre international dataset (Vattikuti Global Quality Initiative on Robotic Urologic Surgery)
Nicholas Corsi	Estimating recurrence free survivability of Non-Muscle Invasive Bladder Cancer (NMIBC) after intravesical therapy: A clinical-based recursive partition analysis
Modonutti	A multi-trial based external validation of the Halabi nomogram in predicting the overall survival of metastatic castration-resistant prostate cancer patients
Chandler Bronkema	National Cancer Database analysis assessing the impact of treatment modalities on survival outcomes in localized neuroendocrine prostate adenocarcinoma
Akshay Sood	Anti-androgen therapy overcomes the time-delay in initiation of salvage radiation therapy and rescues the oncological outcomes in men with recurrent prostate cancer after radical prostatectomy: A post-hoc analysis of the RTOG 9601 trial data

EAU VUI 2020 Presentations

Presentor	Presentation
Marcus Jamil	PT182: Long-term risk of recurrence in surgically treated renal cell carcinoma: A post-hoc analysis of the Eastern Cooperative Oncology Group - American College of Radiology Imaging Network E2805 Trial cohort
Firas Abdollah	684: External validation of genomic classifier based risk-stratification tool to identify candidates for adjuvant radiation therapy in patients with prostate cancer
Marcus Jamil	PT182: Long-term risk of recurrence in surgically treated renal cell carcinoma: A post-hoc analysis of the Eastern Cooperative Oncology Group - American College of Radiology Imaging Network E2805 Trial cohort
Chandler Bronkema	1118: Impact of treatment modality on overall survival (OS) in localized ductal prostate adenocarcinoma (PCa): A national cancer database (NCDB) analysis
M Bhandari	PT186: Predicting intraoperative complications and 30-days morbidity using machine learning techniques for patients undergoing robotic partial nephrectomy (RPN)
Cone, EB	576: Lower odds of cardiac events for gonadotropic releasing hormone antagonists versus agonists
Cone, EB	565: Abiraterone is associated with higher odds of cardiac complications compared to enzalutamide
Veccia, A	164: Robotic radical nephroureterectomy for upper tract urothelial carcinoma: data from the ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) collaborative group
Cone, EB	718: Checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy
Veccia, A	161: Safety profile of robotic vs laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: data from the ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) collaborative group
M Bhandari	P0332: Complexities in annotating surgical videos for building supervised deep learning models for critical steps of laparoscopic live donor nephrectomy

EAU VUI 2019 Presentations

Presentor	Presentation
Sohrab Arora	162: Rare histological variants of prostate adenocarcinoma (PCa): A National Cancer Database (NCDB) analysis
Akshay Sood	PT389: Extended lymph node dissection is associated with improved overall survival in patients with very high-risk prostate cancer: A national cancer database analysis
Firas Abdollah	473: Menon-precision prostatectomy (MPP): An idea, development, exploration, assessment, long-term follow-up (IDEAL) stage 1 study
Akshay Sood	650: Rates and patterns of metastases in patients with node-negative prostate cancer at radical prostatectomy that experience PSA failure: Post-hoc analysis of RTOG 9601 trial data
Firas Abdollah	647: Evaluating the impact of lead-time bias on the observed efficacy of early salvage radiation therapy in prostate cancer: A post-hoc analysis of the RTOG 9601 trial
Nikola Rakic	723: Persistent under-utilization of adjuvant radiotherapy in patients with adverse pathological features at radical prostatectomy: A national cancer database (NCDB) analysis
Sohrab Arora	1036: Inpatient morbidity and cost of cytoreductive radical prostatectomy in the United States
Alexander P Cole	639: A smartphone-based mobile health app to address the adverse effects of androgen deprivation therapy in men with prostate cancer
Akshay Sood	PT389: Extended lymph node dissection is associated with improved overall survival in patients with very high-risk prostate cancer: A national cancer database analysis
Sohrab Arora	874: Testing the external validity of CARMENA trial comparing sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma
Sohrab Arora	1194: Feasibility of omitting outer (cortical) renorrhaphy during robotic partial nephrectomy - a multi-institutional analysis
Fotouhi	PT374: The changing face of surgically treated low-risk prostate cancer (PCa): A national cancer database (NCDB) analysis
Amit Patel	910: Patterns of renal mass biopsy across the MUSIC-KIDNEY statewide QI collaborative
Sohrab Arora	162: Rare histological variants of prostate adenocarcinoma (PCa): A National Cancer Database (NCDB) analysis
Firas Abdollah	PT282: Defining the indications for pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients within a statewide quality improvement collaborative
Tan WS	222: Variation in positive surgical margin status following radical prostatectomy for pT2 prostate cancer
Alexander P Cole	PT322: The contribution of demographic, access and treatment-related factors on racial disparities in bladder cancer

EAU VUI 2018 Presentations

Presentor	Presentation
Firas Abdollah	162: Assessing the external validity of the updated prostate cancer (PCa) intervention versus observation trial (PIVOT)
Firas Abdollah	162: Assessing the external validity of the updated prostate cancer (PCa) intervention versus observation trial (PIVOT)
Von Landenberg	90: Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy
Fletcher, S	1070: Contemporary national trends in localized prostate cancer risk profile at diagnosis
Zaffuto, E	675: Which patients with low-risk prostate cancer are still receiving radical prostatectomy? Impact of patient selection on inverse stage migration at two European, tertiary referral centers
Bandini	PT123: Increasing trend of non-interventional treatment management in patients candidate to active surveillance with localized prostate cancer
Marchioni, M	1041: Comparison of partial vs. radical nephrectomy effect on other cause mortality, cancer specific mortality and 30-day mortality in patients older than 75 years
Bandini	822: Contemporary trends and survival outcomes after aborted radical prostatectomy in lymph node metastatic prostate cancer patients

EAU VUI 2017 Presentations

Presentor	Presentation
Mani Menon	936: Urinary continence, sexual function and biochemical recurrence 12 months following robot-assisted radical prostatectomy: A randomized controlled study comparing the Bocciardi and Menon techniques
Christian Meyer	533: Antimuscarinic use in the elderly: A poisoned apple?
Thomas Seisen	274: Comparative effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder
Björn Löppenberg	794: Variation in the use of active surveillance for low-risk prostate cancer
Christian Meyer	181: Comparative effectiveness of transurethral resection techniques for benign prostatic hyperplasia – analysis of an all payer in patient discharge database
Mani Menon	936: Urinary continence, sexual function and biochemical recurrence 12 months following robot-assisted radical prostatectomy: A randomized controlled study comparing the Bocciardi and Menon techniques
Thomas Seisen	172: Adjuvant chemotherapy vs. observation following radical cystectomy for pT3-4 and/or pN+ urothelial carcinoma of the bladder previously treated with neoadjuvant chemotherapy
Philipp Gild	238: The use of prostate-specific antigen screening in purchased versus direct care settings: Data from the TRICARE military database
Thomas Seisen	173: Comparative effectiveness of selective adjuvant versus systematic neoadjuvant chemotherapy-based strategy for muscle-invasive urothelial carcinoma of the bladder
Deepansh Dalela	951: Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer: Development and internal validation of a multivariable prognostic model
Philipp Gild	648: Contemporary incidence and epidemiologic trends of brain metastases at renal cell carcinoma diagnosis
Björn Löppenberg	800: Variation in prostate cancer care at commission on cancer designated facilities

EAU VUI 2016 Presentations

Presentor	Presentation
Akshay Sood	485: Complications after adrenalectomy – does the speciality matter?
Gandaglia	409: Preoperative predictors of renal failure after robot-assisted partial nephrectomy: Analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database
Akshay Sood	715: Robotic kidney transplantation with regional hypothermia: Results from a prospective two-arm non-randomized controlled trial (Ideal phase 2b)
Christian Meyer	669: Surgeon and hospital variation in the costs of robot-assisted radical prostatectomy in the United States
Christian Meyer	755: Trends of metastasectomy for metastatic renal cell carcinoma and their impact on overall survival
Ross, A	435: Efficacy of early and delayed radiation in a prostatectomy cohort adjusted for genomic and clinical risk
Khurshid R Ghani	364: Assessment of surgical competency for robot-assisted radical prostatectomy: Development and validation of Prostatectomy Assessment and Competency Evaluation (PACE)
Hanna, N	94: Informed decision-making for prostate-specific antigen screening
Christian Meyer	93: A nationwide survey of prostate specific antigen based screening and counseling for prostate cancer
Deepansh Dalela	412: Outcomes of robot-assisted partial nephrectomy in patients with complex renal tumours and pre-existing chronic kidney disease in a multi-institutional, multinational database
Christian Meyer	71: Morbidity, mortality and costs of treatment for locally advanced prostate cancer: A population-based analysis comparing radical prostatectomy and external beam radiation
Christian Meyer	90: Differences in prostate specific antigen testing among urologists and primary care providers in the United States following the 2011 USPSTF recommendations
Björn Löppenberg	7: Sling procedures for female stress incontinence: Does surgical specialty matter?
Christian Meyer	443: Minimally invasive vs open radical prostatectomy: An analysis of 30-day postoperative complications, unplanned readmissions, and mortality
Malte W Vetterlein	632: Radical cystectomy for bladder cancer vs non-malignant indications: Preoperative predictors of perioperative outcomes in a sample of 3269 patients

EAU VUI 2015 Presentations

Presentor	Presentation
Deepansh Dalela	923: Impact of annual surgical volume on outcomes of robot-assisted partial nephrectomy in a multi-institutional, multinational cohort
Fossati, N	801: The impact of insurance status on tumor characteristics and treatment selection in contemporary prostate cancer patients
Fossati, N	823: Contemporary management of prostate cancer patients suitable for active surveillance: A population-based study
Larcher, A	924: Predicting perioperative outcomes of robot assisted partial nephrectomy: The role of hospital case volume in the early phase of adoption
Hanske, J	1060: Female urethral diverticulectomy perioperative outcomes of a multi-institutional prospective database
Marianne Schmidt	641: Racial disparities in the surgical care of localized prostate cancer
Hanske, J	337: Perioperative outcomes of open versus minimally invasive nephroureterectomy: An analysis of 896 patients from the ACS NSQIP database
Hanske, J	599: The impact of metastatic disease at retroperitoneal lymph node dissection for testis cancer on postoperative outcomes
Hanske, J	1059: Vesico-vaginal fistula repair: Perioperative outcomes of abdominal vs vaginal approaches
Akshay Sood	611: Incidence, national trends and disparities in the surgical management for testicular torsion in boys
Christian Meyer	620: Open versus robot-assisted radical prostatectomy: A contemporary analysis of an all-payer discharge database
Roghmann, F	435: Perioperative outcomes after radical cystectomy at NCI-designated centers: Are they any better?
Christian Meyer	442: The impact of preoperative hypoalbuminemia on perioperative outcomes after radical cystectomy in 1,262 patients
Christian Meyer	436: Predictors of wound dehiscence in a prospective dataset of 2,586 cystectomies
James O Peabody	192: Wisdom of the crowds: Use of crowdsourcing to assess surgical skill of robot-assisted radical prostatectomy in a statewide surgical collaborative
Firas Abdollah	1011: Adjuvant radiotherapy in prostate cancer patients treated with surgery: The impact of age and tumour characteristics
Firas Abdollah	638: Androgen deprivation therapy and increased non-cancer mortality in prostate cancer patients: Analysis of the number needed to harm
Khurshid R Ghani	483: Video-based independent peer review of robot-assisted radical prostatectomy in a statewide quality improvement collaborative
Firas Abdollah	1016: Long-term clinical recurrence (CR) rate in prostate cancer (PCa) patients with adverse pathological characteristics at robotic-assisted laparoscopic radical prostatectomy (RALP)
Akshay Sood	842: Robotic kidney transplantation with regional hypothermia: Results from a prospective two-arm non-randomized controlled trial (Ideal Phase 2b)
Akshay Sood	978: Robotic anatrophic nephrolithotomy using near infra-red fluorescence image-guidance: Idea, Development, Exploration, Assessment and Long-term monitoring (IDEAL) phase 0 study
Deepansh Dalela	921: Perioperative and functional outcomes of robot-assisted partial nephrectomy for renal tumors >4 cm in a multi-institutional, multinational cohort
Firas Abdollah	938: When should a positive surgical margin (SM) ring a bell? An analysis of a multi-institutional Robotic-Assisted Laparoscopic radical Prostatectomy (RALP) database
Firas Abdollah	191: Cancer-control outcomes in patients with clinically high-risk prostate cancer (PCa) treated with robotic-assisted laparoscopic radical prostatectomy (RALP): A multi-institutional database analysis

EAU VUI 2014 Presentations

Presentor	Presentation
Roghmann	645: Radical prostatectomy vs radiotherapy among older patients with clinically advanced prostate cancer
Shoshtari	428: Comparison of peri-operative outcomes of robotic partial nephrectomy and laparoscopic partial nephrectomy in surgical treatment of small renal masses
Hay, D	877: Systematic review of effectiveness of mentorship programmes in urology

EAU VUI 2013 Presentations

Presentor	Presentation
Khurshid R Ghani	260: Outcomes for open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: Results from the Nationwide Inpatient Sample
Jesse Sammon	915: Robot-assisted vs open radical prostatectomy: A comparison of outcomes across procedure type and volume quartile
Hanhan Li	119: Utilization and peri-operative outcomes of robot-assisted and open vaginal vault suspension
Wooju Jeong	709: Bimanual examination of retrieved specimen during robot-assisted radical prostatectomy: A novel technique for reducing the positive surgical margin
Ramesh Kumar	Complications during robot-assisted kidney surgery
Wooju Jeong	Bimanual examination of retrieved specimen and selective hypothermia during robot-assisted radical prostatectomy
Jesse Sammon	158: Socioeconomic trends and utilization in the emergency department treatment of urinary tract infections
Kaczmarek	876: Perioperative and functional outcomes of robotic assisted partial nephrectomy without hilar clamping: A multi-institutional propensity score analysis
Khurshid R Ghani	260: Outcomes for open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: Results from the Nationwide Inpatient Sample
Khurshid R Ghani	659: Trends in utilization and outcomes for percutaneous nephrolithotomy in the United States
Jesse Sammon	915: Robot-assisted vs open radical prostatectomy: A comparison of outcomes across procedure type and volume quartile
Jesse Sammon	1070: Trends in utilization and comparative outcomes for infected upper urinary tract stones in the United States: PCN vs stent
Jesse Sammon	497: Live donor nephrectomy vs kidney transplants in minority populations: A population based analysis of trends
Jesse Sammon	158: Socioeconomic trends and utilization in the emergency department treatment of urinary tract infections
Jesse Sammon	625: Predictors of admission in patients presenting to the emergency department with urinary tract infection
Khurshid R Ghani	657: It’s getting hot in here! Monthly variation in emergency department visits for upper urinary tract calculi in the United States
Penna, FJ	526: Prevalence and temporal trends in admissions for urolithiasis in children
Shyam Sukumar	534: Correction of ureteropelvic junction obstruction in children: National trends and comparative effectiveness in operative outcomes
Khurshid R Ghani	369: Acute imaging for hematuria in the United States: Costs and predictors from the Nationwide Emergency Department Sample
Craig G Rogers	885: Intracorporeal cooling and extraction (I.C.E.) technique of robotic partial nephrectomy: Emulating the open approach
Craig G Rogers	Robotic partial nephrectomy with cold ischemia and early tumor extraction: Recapitulating the open approach

EAU VUI 2012 Presentations

Presentor	Presentation
Quoc-Dien Trinh	Complications during robot-assisted kidney surgery
Quoc-Dien Trinh	Enucleation techniques for challenging robot-assisted partial nephrectomy cases
Khurshid R Ghani	Robot-assisted retroperitoneal lymph node dissection: Modified nerve-sparing left sided template
Quoc-Dien Trinh	679: Perioperative outcomes of robot-assisted radical prostatectomy vs. open radical prostatectomy
Khurshid R Ghani	1061: Accurate prediction of erectile function following robot-assisted radical prostatectomy
Quoc-Dien Trinh	134: Disparities in the utilization of partial nephrectomy in The United States: A case for concern?
Quoc-Dien Trinh	677: The effect of hospital vs. surgical volume on outcomes after radical prostatectomy: A head-to-head comparison using decision-curve analyses

NARUS and World Congress Presentations

UI presentations at NARUS 2017

Presentor	Presentation
Sohrab Arora, Rajesh Ahlawat.	Robot assisted partial nephrectomy for complex renal hilar tumors: Technical caveats. Presented at the North American Robotic Urology Symposium, Las Vegas, February 2017.
Sohrab Arora, Rajesh Ahlawat	Robotic Excision Of A Functioning Hilar Paraganglioma With Reconstruction of Renal Vessels. Presented at the North American Robotic Urology Symposium, Las Vegas, February 2017.
Sohrab Arora, Rajesh Ahlawat.	A novel technique of intrafascial robotic radical prostatectomy with combined anterior-posterior approach to preserve continence mechanism - A Feasibility study. Presented at the North American Robotic Urology Symposium, Las Vegas, February 2017. Won the second prize for the best video
Deepansh Dalela, Wooju Jeong, Madhu-Ashni Prasad, Akshay Sood, Firas Abdollah, Patrick Karabon, Mireya Diaz, Jesse Sammon, Marcus Jamil, Brad Baize, Andrea Simone, Mani Menon	A pragmatic randomized controlled trial examining the impact of the Retzius- sparing approach on early urinary continence recovery after robot-assisted radical prostatectomy - Awarded Best Poster
Mani Menon, Deepansh Dalela, Madhu-Ashni Prasad, Marcus Jamil, Akshay Sood, Firas Abdollah, Patrick Karabon, Mireya Diaz, Jesse Sammon, Christopher Tallman, Brad Baize, Andrea Simone, Wooju Jeong	Functional recovery, oncologic outcomes and postoperative complications 12 months following robot-assisted radical prostatectomy: results of an evidence- based analysis comparing the ‘Bocciardi’ and ‘Menon’ techniques
Mani Menon, Deepansh Dalela, Madhu-Ashni Prasad, Marcus Jamil, Akshay Sood, Firas Abdollah, Patrick Karabon, Mireya Diaz, Jesse Sammon, Christopher Tallman, Brad Baize, Andrea Simone, Wooju Jeong	Learning Curve and patient safety monitoring for an experienced surgeon performing a new procedure: results from an IDEAL Phase 3 study comparing two techniques if robot-assisted radical prostatectomy.

World Congress of Endourology 2017

Presentor	Presentation
Sohrab Arora, Rajesh K. Ahlawat, Ronney Abaza, James Adshead, Ben Challacombe, Prokar Dasgupta, Giorgio Gandaglia, DA Moon, Giacomo Novara, F Porpiglia, James Porter, Alex Mottrie, Mahendra Bhandari, Craig Rogers.	Trifecta outcomes of robot-assisted partial nephrectomy in solitary kidney - A GQI-RUS database analysis.
Sohrab Arora, Rajesh K. Ahlawat, Ronney Abaza, James Adshead, Ben Challacombe, Prokar Dasgupta, Giorgio Gandaglia, DA Moon, Giacomo Novara, F Porpiglia, Alex Mottrie, Mahendra Bhandari, Craig Rogers and James Porter.	Retroperitoneal vs. transperitoneal robot assisted partial nephrectomy – an propensity score weighted comparison in the GQI-RUS database analysis.
Sohrab Arora, Rajesh K. Ahlawat, Ronney Abaza, James Adshead, Ben Challacombe, Prokar Dasgupta, Giorgio Gandaglia, DA Moon, Giacomo Novara, F Porpiglia, James Porter, Alex Mottrie, Mahendra Bhandari, Craig Rogers.	A Vattikuti Collective Quality Initiative database analysis.
Harmanjit Gill, Craig Rogers	Outcomes of robot-assisted partial nephrectomies in high volume centers continue to improve for several years after the initial learning curve – Poster Presentation
Harmanjit Gill, Craig Rogers	Concurrent robotic kidney and general surgery procedures – Video Abstract